Navigation Links
Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
Date:1/29/2008

Weighted average

number of shares

outstanding: 13,235,755 13,235,755

Table 5

Amicus Therapeutics, Inc.

Reconciliation of GAAP to non-GAAP Measures for the

Statement of Operations Information for Year Ended December 31, 2006

(Unaudited)

(In thousands, except share and per share amounts)

Change

in Fair

Value of Preferred

Non- Warrant Stock Deemed Stock GAAP as

GAAP Liability Accretion Dividend Compensation Reported

Income Statement

Classifications:

Research and

development $(31,924) $- $- $- $(1,706) $(33,630)

General and

administrative (10,733) (1,544) (12,277)

Depreciation and

amortization (952) (952)

Interest income 1,990 1,990

Interest expense (273) (273)

Change in fair

value of warrant

liability - (23) (23)

Other expense (1,180) (1,180)

Preferred stock

accretion - (159) (159)

Deemed dividend - (19,424) (19,424)

Summary:

Net loss: $(43,072) $(23) $(159) $(19,424) $(3,250) $(65,928)

Net loss per

share - basic

and diluted: $(58.52) $(0.03) $(0.22) $(26.39) $(4.42) $(89.58)

Weighted average

number of shares

outstanding: 735,967 735,967 '/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
2. Amicus Therapeutics to Host R&D Day
3. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
4. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
5. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
6. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
7. Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders
9. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
10. Nile Therapeutics Appoints Gregory W. Schafer to Board of Directors
11. Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 SPIE Fellow Glenn Boreman, ... Optical Science and Director of the Center for Optoelectronics ... at Charlotte, and co-founder and Chairman of the Board ... the 2015 Vice President of SPIE, the international society ... Stahl announced recent election results at the Annual General ...
(Date:8/28/2014)... A new research platform uses a ... tiny structures undergoing stress and heating, an ... designs for microelectronics and batteries., This new ... about how heating and the surface stress ... Researchers have discussed the merits of surface-stress ...
(Date:8/28/2014)... Aug. 28, 2014  Next month, executives from clinical trial ... industry events beginning with Patient-Centered Clinical Trials 2014 , ... Boston , September 4-5. Patient recruitment experts ... Aaron Fleishman will share insights on the benefits of ... of tactics – from media to mobile apps – can ...
(Date:8/28/2014)... by a Florida State University research team has led ... temperature, emit white light, and convert photon energy directly ... a butterfly. , Biwu Ma, associate professor in the ... College of Engineering, created the molecule in a lab ... that his creation has many other unique capabilities. , ...
Breaking Biology Technology:Glenn Boreman, UNC Professor and Plasmonics Co-Founder, Elected to SPIE Presidential Chain 2New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3BBK Worldwide Leads Sessions at Key September Events 2Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 2
... The human eye uses tiny muscles to focus on ... lenses, but some sensors do not require these external ... College of Engineering are investigating a liquid lens ... be used in a variety of commercial applications, including ...
... note: This is the second of a two-part opinion piece on ... M adison, Wis. - The environmental arguments ... that ethanol increases nitrous oxides and ozone. These studies were based ... Environmental Protection Agency , the California Air Resources Board ...
... Madison, Wis. - Madison Area Technical College ... fuel, it will help educate the technicians that will ... , ,The reactor, developed as part of a joint ... , purifies cooking oil recovered from a restaurant's deep ...
Cached Biology Technology:"Smart" lenses hold commercial potential 2Last ethanol article you'll ever need to read, Part II 2Last ethanol article you'll ever need to read, Part II 3Last ethanol article you'll ever need to read, Part II 4MATC bio-diesel reactor to support training 2
(Date:8/28/2014)... your neighbors than traditional cigarettes, but still release ... study from USC. , Scientists studying secondhand smoke ... exposure to harmful particles, with close-to-zero exposure to ... harmful metals in second-hand e-cigarette smoke were found ... contains high levels of polycyclic aromatic hydrocarbons ...
(Date:8/28/2014)... support of peer groups and clinicians is critical ... to recent University of Georgia research. , A ... County area determined that role models for successful ... of infants. , "Mothers who received that support ... said study co-author Alex Anderson, an associate professor ...
(Date:8/28/2014)... are good examples of complex systems. Their infrastructure ... water for cooling, transport to supply fuel, and ... in the network chain is interconnected with a ... A team of UK-based scientists has studied various ... findings have been published in EPJ B by ...
Breaking Biology News(10 mins):Second-hand e-cig smoke compared to regular cigarette smoke 2Breastfeeding study shows need for effective peer counseling programs 2Inter-dependent networks stress test 2
... mental and behavioural development? This question will be addressed ... nutrition next 6th of October in York, at a ... entitled "Effect of diet on the mental performance of ... European Commission through its 7th Framework Programme- is coordinated ...
... This release is available in French . , ... research, McGill University today joined with two leading Swiss research ... Federal Institute of Technology (ETHZ) to enhance neuroscience research ... therapy, Alzheimer,s disease, synapse modelling and repair, neuroimmunology and genetic ...
... years, the horseshoe crab is now under threat ... changes may,also play a role. Researchers from the University ... to natural climate change in a study recently published,in ... horseshoe crab is often regarded as a living fossil, ...
Cached Biology News:Experts will meet to discuss how diet affects behavioral development of children 2McGill partners with leading Swiss neuroscience research group 2Climate change affects horseshoe crab numbers 2
Designed for use with any of the Agencourt kits in tube format....
... is a fluorescent counterstain which ... color. The bright blue fluorescence ... fluorochromes such as rhodamine, Cy3, ... can be used for fluorescent ...
... 20-HETE is a cytochrome P450 (CYP450) metabolite ... the renal and cerebral vasculature. In rat ... mediates pressure-induced autoregulatory vasoconstriction. 20-HETE is excreted ... of free 20-HETE (20-40 pg/ml in human ...
... APAgene kits are designed to rapidly and ... our patented APA Technology. APAgene provides hassle-free, ... price. All necessary ingredients are provided in ... be used for gap filling, localized cloning ...
Biology Products: